NaCl — Competitive Intelligence Brief

NaCl (NaCl) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement. Area: General/Supportive Care.

marketed Electrolyte replacement General/Supportive Care Small molecule

Target snapshot

NaCl (NaCl) — University Hospital, Limoges. Sodium chloride (NaCl) is an electrolyte that restores and maintains normal sodium and chloride ion balance in the body.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
NaCl TARGET	NaCl	University Hospital, Limoges	marketed	Electrolyte replacement
Potassium Phosphates	Potassium Phosphate, Dibasic	Pfizer	marketed	Electrolyte replacement	Phosphorus homeostasis and cellular biochemical functions	1993-01-01
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
fisiologic serum	fisiologic serum	Hospital Universitari Vall d'Hebron Research Institute	marketed	Electrolyte replacement solution
Sterile Sodium Chloride	Sterile Sodium Chloride	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	marketed	Electrolyte replacement / Crystalloid fluid
% 0.9 Saline solution	% 0.9 Saline solution	Kecioren Education and Training Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
Plasma-lyte (static group)	Plasma-lyte (static group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

• 2026-03-12 — Potassium Phosphates · FDA · approved · US · Pfizer

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement class)

1. Pfizer · 1 drug in this class
2. Radboud University Medical Center · 1 drug in this class
3. University Hospital, Limoges · 1 drug in this class